• Contact Us
Pharmaceuticals & Life Sciences Blogs - VWV

Pharma & Life Sciences

Articles & Blogs Pharma & Life Sciences

How Might Blockchain Impact the Pharmaceutical Supply Chain?

Monday, 18 January 2021

Distributed ledger technologies have continued to attract a great amount of interest from governments, businesses and consumers in 2021.

How Might Blockchain Impact the Pharmaceutical Supply Chain?

Articles & Blogs Pharma & Life Sciences

New Vaccine Hub Heralds Exciting New Era in India-UK Life Sciences Relations

Monday, 11 January 2021

Following Brexit, the UK is looking for new international trade opportunities. In life sciences as well as other sectors, where better to push on than with India? That seems to be the UK Government's view.

New Vaccine Hub Heralds Exciting New Era in India-UK Life Sciences Relations

Articles & Blogs Brexit Pharma & Life Sciences

New UK-EU Deal - What Does It Mean for Life Sciences?

Monday, 11 January 2021

Well, it finally happened. After months of complex negotiations and stand-offs that took Europe to the brink and back, the EU and UK finally agreed a trade and co-operation deal on Christmas Eve.

New UK-EU Deal - What Does It Mean for Life Sciences?

Articles & Blogs Information Law Pharma & Life Sciences

European Commission Publishes Draft Model Clauses for Controller / Processor Contracts

Wednesday, 16 December 2020

The European Commission has published draft standard contractual clauses for inclusion in contracts between controllers and processors.

European Commission Publishes Draft Model Clauses for Controller / Processor Contracts

Articles & Blogs Data Protection Pharma & Life Sciences

The End of Privacy Shield and New Requirements For Standard Contractual Clauses: What 'Schrems II' Means For Your International Data Transfers

Wednesday, 16 December 2020

In July 2020, the European Court of Justice dealt a major blow to organisations that transfer personal data to the US and other jurisdictions, primarily with the striking down of the EU-US Privacy Shield.

The End of Privacy Shield and New Requirements For Standard Contractual Clauses: What 'Schrems II' Means For Your International Data Transfers

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

Coronavirus Hits UK Pharma Sales

Wednesday, 16 December 2020

Many industries have been hit by coronavirus (COVID-19). To some people's surprise, this has also been in pharma, as can be seen from the latest results from GlaxoSmithKline (GSK) and AstraZeneca (AZ).

Coronavirus Hits UK Pharma Sales

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

Cell and Gene Therapy Catapult Manufacturing Space Soars in 2020 Despite Pandemic

Wednesday, 16 December 2020

The UK is leading the way when it comes to advanced therapies, as we heard recently at the 2020 PING Conference - Britain's Great Life Sciences Future: Genomics Personalised Medicine and AI.

Cell and Gene Therapy Catapult Manufacturing Space Soars in 2020 Despite Pandemic

Articles & Blogs Pharma & Life Sciences

European Court Allows Limited National Laws to Interfere with Online Pharmacy Sales

Tuesday, 10 November 2020

The European Court of Justice (ECJ) has given a judgment on the extent to which the application of national laws regulating medicines can limit the activities of online pharmacies.

European Court Allows Limited National Laws to Interfere with Online Pharmacy Sales

Articles & Blogs Pharma & Life Sciences

New MHRA Guidance on Pharma Product Assessment Post-Brexit

Tuesday, 10 November 2020

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a guidance note on new assessment routes for pharmaceutical products from the end of the Brexit transition period.

New MHRA Guidance on Pharma Product Assessment Post-Brexit

Articles & Blogs Pharma & Life Sciences

What Is the Future of Genomics in the UK?

Tuesday, 10 November 2020

The UK marked its place as the frontrunner in the field of genomics many years ago when it created genomics focused institutions such as the UK BioBank and Genomics England...

What Is the Future of Genomics in the UK?

Articles & Blogs Pharma & Life Sciences

Moving from CE to UKCA Product Marking - 4 Things You Need to Do

Thursday, 15 October 2020

A wide variety of products currently sold in the UK are required to bear a 'CE' marking to show their conformity with various legal requirements.

Moving from CE to UKCA Product Marking - 4 Things You Need to Do

Articles & Blogs Pharma & Life Sciences

Stevenage Named High Potential Opportunity Zone for Cell and Gene Therapy

Thursday, 15 October 2020

Stevenage has been classified by the Department for International Trade (DIT) as a High Potential Opportunity (HPO) zone in recognition of its leading cell and gene therapy cluster.

Stevenage Named High Potential Opportunity Zone for Cell and Gene Therapy

Articles & Blogs Pharma & Life Sciences

What Is the Value of Community Pharmacy in England Under COVID-19?

Thursday, 15 October 2020

Whilst the Government has been singing the praises of workers in the NHS, particularly those working in hospitals, one sector of health professionals that have been working throughout the pandemic has hardly received a mention.

What Is the Value of Community Pharmacy in England Under COVID-19?

Articles & Blogs Brexit Pharma & Life Sciences

State Aid - Brexit Roadblock or New Opportunities?

Thursday, 15 October 2020

Many in the pharma and life sciences sector have expressed concern over the seemingly low prospects of a trading deal between the EU and UK after the end of the Brexit transition period on 31 December 2020...

State Aid - Brexit Roadblock or New Opportunities?

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

How Is Coronavirus Affecting Clinical Trials and Future Innovation in the UK?

Wednesday, 16 September 2020

A recent analysis by the University of Southampton has shown the devastating effect of the coronavirus (COVID-19) pandemic on the early stage research space through the suspension of over 9,000, and cancelling of over 1,000, clinical trials in the UK.

How Is Coronavirus Affecting Clinical Trials and Future Innovation in the UK?